prostate cancer

Hormone therapy can speed prostate cancer spread. University of Rochester researchers say their findings "may revolutionize the way we combat prostate cancer."

(Elsevier) Nerve-sparing radical prostatectomy is the gold-standard therapy for prostate cancer in men with a life expectancy of 10 years or more.

(Elsevier) Studies have shown that approximately 16 percent of patients with localized prostate cancer regret their treatment choice.

PHILADELPHIA (AP) -- A Philadelphia veterans hospital says it may have given insufficient radiation treatment to more than 100 prostate-cancer patients....

(Wiley-Blackwell) A new analysis finds that one in five men in their 40s has had a prostate specific antigen test within the previous year and that young black men are more likely than young white men to have undergone the test.

A U.S. government task force says there is no "adequate proof" that routinely screening men over age 75 for prostate cancer leads to fewer deaths.

NEW YORK (AP) -- Doctors should stop routine prostate cancer screening of men over 75 because there is more evidence of harm than benefit, a federal task force advised Monday in a new blow to a much scrutinized medical test....

The blood test millions of men undergo each year to screen for prostate cancer leads to so much unnecessary anxiety, surgery and complications that doctors should stop testing elderly men, and it remains unclear whether the test is worthwhile for younger men, a federal task force concluded today.

Androgen deprivation therapy, a treatment most often offered for men in late stages of prostate cancer may affect mental functioning.

(Wiley-Blackwell) Hormone deprivation therapy, a used for prostate cancer, may have subtle adverse effects on cognition in patients.